AI Verdict
LEXX has stronger fundamentals based on our AI analysis.
LFST vs LEXX Fundamental Comparison
| Metric | LFST | LEXX |
|---|---|---|
| Revenue | $1.4B | $0.0 |
| Net Income | $9.7M | $-1.6M |
| Net Margin | 0.7% | N/A |
| ROE | 0.6% | -32.5% |
| ROA | 0.4% | -26.4% |
| Current Ratio | 1.65x | 3.68x |
| Debt/Equity | 0.19x | 0.00x |
| EPS | N/A | $-0.07 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LFST vs LEXX: Frequently Asked Questions
Is LFST or LEXX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LEXX has stronger fundamentals. LFST is rated SELL (70% confidence) while LEXX is rated SELL (72% confidence). This is not investment advice.
How does LFST compare to LEXX fundamentally?
LifeStance Health Group, Inc. has ROE of 0.6% vs Lexaria Bioscience Corp.'s -32.5%. Net margins are 0.7% vs N/A respectively.
Which stock pays higher dividends, LFST or LEXX?
LFST has a dividend yield of N/A or no dividend while LEXX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LFST or LEXX for long term?
For long-term investing, consider that LFST has SELL rating with 70% confidence, while LEXX has SELL rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LFST vs LEXX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LFST vs LEXX, the AI consensus favors LEXX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.